Partial Pulpotomy Comparing Two Tricalcium Silicate Cement as Pulp Capping Material in Permanent Teeth with Cariously exposed Pulp in Adult Patients.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

TCTR

Registry ID

TCTR20171228003

Enrollment

Registered

2017-12-28

Start date

2015-01-09

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

permanent teeth of adult patients with carious exposure. MTA Biodentine clinical trial caries partial pulpotomy

Interventions

MTA (Mineral trioxide aggregate) is the gold standard pulp capping matherial.,Biodentine is a recently introduce hydrolic calcium silicate cement.

Experimental Drug,Experimental Drug

MTA partial pulpotomy,Biodentine

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Permanent teeth with carious exposure in adult age 18 years old and over.

Exclusion criteria

Exclusion criteria: systemic diseases with bleeding disoder

Design outcomes

Primary

Measure	Time frame
Clinical success rate at one year 1 year Clinical symptom and radiographic finding	—

Secondary

Measure	Time frame
post operative pain at 1, 3, 7 days pain score	—

Countries

Thailand

Contacts

Public ContactPatchanee Chiveera

Chiangmai university

patchnee.chu@gmail.com0857162130

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026